Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Israeli intelligence ‘dismissed’ detailed warning of Hamas raid
    • Argentina’s Javier Milei backs away from dollarisation as central bank pick rejects role
    • Geert Wilders faces early setback in Dutch coalition talks
    • Hamas releases 24 hostages as Israel truce takes hold
    • Cathay Pacific offers cheap flights to help Hong Kong’s ‘patriots only’ vote
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • KPMG extends pay freeze to 12,000 UK staff
      • Tesla strikes in Sweden are ‘insane’, says Elon Musk
      • How BP’s ‘Sun King’ court enabled the rise and fall of Bernard Looney
      • Jeff Zucker hits out at rival Telegraph bidders for ‘slinging mud’
      • Boots offloads £4.8bn pension scheme to Legal & General
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Wealth Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Argentina’s Javier Milei backs away from dollarisation as central bank pick rejects role
      • News updates from November 24: Hamas releases hostages as Israel truce begins, Netherlands’ VVD party deals blow to Geert Wilders’ government hopes
      • How BP’s ‘Sun King’ court enabled the rise and fall of Bernard Looney
      • Investors dump dollar in bet that US rates have peaked
      • Montenegro court clears crypto chief Do Kwon for extradition
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • OpenAI has just fused its corporate ‘kill switch’
      • Europe’s problem? It’s too attractive
      • Crypto power struggle enters new stage with Binance settlement
      • Slaying the worklessness monster is a thankless but crucial task
      • A much-needed truce between Israel and Hamas
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
      Most Read
      • Business Books: What to read this month
      • Brexit negotiator Michel Barnier: ‘The EU is not the same one the UK left’
      • In search of chief executives who never grow ‘old’
      • Start-ups challenge culture of the Japanese salaryman
      • The inescapable tyranny of the bad boss
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Tom Hanks: ‘I was a pretty lucky guy’
      • Why the breakdown of the 9-to-5 job is making us lonelier
      • Leon Black’s downfall confounds the legacy of #MeToo on Wall Street
      • The most decorated mountaineer ever (and why you’ve never heard of him)
      • Could younger homebuyers turn Belgravia from staid to ‘buzzy’?
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Medical science

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Thursday, 23 November, 2023
      Disease control and prevention
      WHO asks China for data on ‘undiagnosed pneumonia’ cases

      Health body’s concern reflects heightened vigilance over signs of disease outbreaks since Covid pandemic

      Children and their parents wait to be seen at a children’s hospital in Beijing
    • Monday, 20 November, 2023
      Bayer AG
      Bayer shares plunge after blood-thinning drug trial halted

      German group says prospective blockbuster asundexian failed to demonstrate efficacy

      The Bayer logo
    • Thursday, 16 November, 2023
      Artificial intelligence
      AI boosts breast cancer detection rates, new research shows

      Study shows potential of technology to improve and speed up medical diagnoses

      Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma: AI analysis flagged up to 13 per cent more cases than doctors had identified
    • Thursday, 16 November, 2023
      UK approves Crispr gene editing therapy in global first

      Regulator authorises treatment for sickle cell disease and beta thalassaemia

      A scientist at Vertex Pharmaceuticals
    • Wednesday, 15 November, 2023
      Biotech
      Biotech raises funds to find cancer treatments using transgenic mice

      T-Therapeutics hopes to use genetically engineered rodents and machine learning to discover drugs

      Allan Bradley, founder of T-Therapeutics
    • Wednesday, 15 November, 2023
      FT SeriesTech Champions
      Airfinity gives decision makers big picture on health

      Covid may have abated, but emerging diseases and new drug categories are keeping the analytics firm busy

      Portrait of Airfinity founder Rasmus Bech Hansen
    • Saturday, 11 November, 2023
      Novo Nordisk AS
      Novo Nordisk’s obesity drug cuts risk of death by 18%, trial data shows

      Wegovy found to have ‘quite profound’ effect on reducing risk of heart attacks, says pharma group

      A 0.25 mg injection pen of Novo Nordisk’s weight-loss drug Wegovy
    • Thursday, 9 November, 2023
      AstraZeneca PLC
      AstraZeneca signs deal for oral obesity drug and lifts profit outlook

      Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid jabs

      An AstraZeneca facility in Sweden
    • Thursday, 9 November, 2023
      Pharmaceuticals sector
      Approval for Eli Lilly obesity drug sets up rival to Wegovy

      US and UK regulators say diabetes medication showed ‘significant’ weight loss benefits

      Eli Lilly headquarters in Indianapolis, Indiana,
    • Thursday, 2 November, 2023
      Disease control and prevention
      ‘Spillover events’ from zoonotic diseases threaten surge in deaths, research warns

      Findings show need to mitigate growing risks posed by animal-to-human pathogens such as coronaviruses

      An Ebola virus
    • Thursday, 2 November, 2023
      Smart rats show human-like powers of imagination in neural research

      Findings could boost development of medical technology such as brain-machine interfaces

      A scene from ‘Ratatouille’
    • Monday, 30 October, 2023
      Willy Shih
      What the ubiquitous syringe tells us about US supply chains

      Domestically made products like syringes currently cost more than those produced in China

      A BD needle ready for use
    • Monday, 30 October, 2023
      The Big Read
      What is behind the unexpected decline in dementia?

      Emerging research is challenging a widely held belief that new cases of the condition will rise exponentially as people live longer

    • Sunday, 29 October, 2023
      Griffin and Schmidt invest $10mn each in UK genetics database

      UK Biobank’s records of 500,000 people promise breakthroughs in diseases and ageing

      Biobank data storage facility in Stockport
    • Wednesday, 25 October, 2023
      Drugs research
      New studies find benefits in very early drug treatment of Alzheimer’s

      Pioneering medicines developed by Eisai and Eli Lilly shown to be more effective when taken earlier

      Screen showing brain patterns of an Alzheimer’s patient
    • Friday, 20 October, 2023
      LexAmerican Express Co
      Amex: corporate spending slowdown need not jangle nerves

      US businesses are tightening their belts, but Amex is bolstered by its affluent customer base

      American Express boss Steve Squeri
    • Friday, 20 October, 2023
      Scientists express cautious optimism about decline in bird flu

      Virus is affecting fewer birds this autumn while avian immunity is increasing

      A gannet landing on Bass Rock in the Firth of Forth, Scotland
    • Tuesday, 17 October, 2023
      Coronavirus
      UK coronavirus response hampered by ‘Chinese wall’, former adviser claims

      Professor Neil Ferguson tells public inquiry experts had ‘almost no visibility’ of government preparedness

      A video screengrab of Professor Neil Ferguson
    • Tuesday, 17 October, 2023
      Disease control and prevention
      Global warning system essential to beat future pandemics, says Cepi chief

      Call for rapid detection comes as pharma groups criticise draft WHO treaty on how to avoid another health crisis

      Richard Hatchett
    • Wednesday, 11 October, 2023
      World-first trial of gene therapy to cure form of deafness begins

      Children from the UK, Spain and the US are being recruited in bid to transform treatment of auditory neuropathy

      A doctor examines the ear drum of a young girl
    • Tuesday, 10 October, 2023
      Genomics
      Scientists alter chickens’ DNA to reduce spread of bird flu

      Gene editing interventions could be cost-effective way to reduce transmission of avian influenza viruses

      Battery hens in a chicken shed
    • Monday, 9 October, 2023
      Coronavirus treatment
      Covid antivirals lose spark as regulatory scrutiny increases

      Doubts grow over safety and effectiveness of drugs that were marketed as coronavirus treatments

      A person dressed in a white clinical coat holds a box of the pills up in front of a larger cardboard box containing dozens more samples
    • Sunday, 8 October, 2023
      Dementia
      UK biotech group raises £48mn for Alzheimer’s research

      AstronauTx’s financing is step towards helping millions of people suffering from disease

    • Friday, 6 October, 2023
      Disease control and prevention
      Oxford vaccine developer criticises WHO’s mid-2024 target for malaria shot

      Adrian Hill urges swifter rollout, saying ‘why would you allow children to die instead of distributing the vaccine?’

      The young boy cries as a nurse administers the injection. His mother, who is holding him, smiles as she looks down on him
    • Wednesday, 4 October, 2023
      Covid-19 vaccines
      Moderna reports trial success for dual Covid and flu vaccine

      Combined jab as effective as separate shots in early stage tests

      The Moderna Covid-19 vaccine is loaded into a syringe
    Previous page You are on page 1 Next page

    Join us at an FT Live event

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT Live
    US Pharma and Biotech Summit
    Exploring trends and innovations in life sciences across the United States
    Tuesday, 14 May 2024New York, NY, USA
    Explore all events

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

    Tools

    PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Israel-Hamas war
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
      • Artificial intelligence
      • Semiconductors
      • Cyber Security
      • Social Media
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Wealth Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      • Working It
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Visual and data journalism
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today’s Newspaper (FT Digital Edition)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In